Keeping the Women we Love Healthy

The question is why are we passionate about women's health research? The need.  Women are not small men. The exclusion of female subjects in current research efforts may result in the misdiagnosis and consequently, erroneous medical treatment of women.  In the era of personalized medicine, a ‘one-size-fits-all’ approach on the basis of results from male research subjects places women at a higher health risk.  We seek to end the bias at a research level. What we do:   The Doris A. Howell Foundation for Women’s Health Research is dedicated to making a long-term, positive impact on women’s health. It is THE premier organization advancing women’s health research. To that extent, the organization: Funds unique undergraduate  research scholarships  and  graduate nursing  research grants  to scientists researching  issues affecting  women’s health.  Presents the latest medical research  findings at our events and through  our Speaker Service progra

Pictured Above: Dr. Brooke Emerling, winner of the Howell Fast Pitch Contest Award; Kathleen Franklin, Howell Foundation Board Member; and Dr. Carole Banka, former Howell Foundation Board Member and Fast Pitch judge.   Actually, we all are winners when it comes to learning about the latest research in metastatic breast cancer (MBC).  While efforts have reduced mortality rates by more than a third, the work in finding the cure has doubled. There are currently more than 150,000 women living with stage IV metastasized breast cancer in the US. The Susan G. Komen Foundation held it second Metastatic Breast Cancer Conference in March, where patients, providers and researchers came together to paint a picture of the current status and advancements in treatments for MBC.  Moderated by Farideh Z. Bischoff, Ph.D and CEO of FreMon Scientific, the program included presentations from a panel of experts in the field: Keith Wilner MD, Executive Director of Oncology at Pfizer,  Svasti Hari